• OPEN AN ACCOUNT
Indian Indices
Nifty
25,227.35 -58.00
(-0.23%)
Sensex
82,288.11 -38.94
( -0.05%)
Bank Nifty
56,625.00 15.25
( 0.03%)
Nifty IT
35,330.80 -278.25
( -0.78%)
Global Indices
Nasdaq
46,089.04 588.43
(1.29%)
Dow Jones
6,674.95 101.44
(1.54%)
Hang Seng
48,192.70 -387.74
(-0.80%)
Nikkei 225
9,442.87 15.40
(0.16%)
Forex
USD-INR
88.75 -0.06
(-0.07%)
EUR-INR
103.09 0.08
(0.07%)
GBP-INR
118.50 -0.08
(-0.06%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Mankind Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543904
INE634S01028
354.6937544
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANKIND
55.7
100787.37
EPS(TTM)
Face Value()
Div & Yield %
43.84
1
0
 

dhatre udyog ltd
Consecutive Investments & Trading Co standalone net profit rises 511.11% in the March 2025 quarter
May 30,2025
Net profit of Consecutive Investments & Trading Co rose 511.11% to Rs 0.55 crore in the quarter ended March 2025 as against Rs 0.09 crore during the previous quarter ended March 2024. Sales reported to Rs 15.21 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.

For the full year,net profit rose 1211.76% to Rs 2.23 crore in the year ended March 2025 as against Rs 0.17 crore during the previous year ended March 2024. Sales reported to Rs 22.60 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales15.210 0 22.600 0
OPM %-0.660 -5.090 -
PBDT0.070.16 -56 2.320.19 1121
PBT0.070.16 -56 2.320.19 1121
NP0.550.09 511 2.230.17 1212